LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Abstract WMP3: DEFUSE-3 Eligible but DAWN Ineligible Patients Treated Within 16-24 Hours: Results From BEST Prospective Cohort Study

Photo by joelfilip from unsplash

Background: The 2018 ASA guidelines recommend endovascular stroke treatment (EVT) for patients who meet DEFUSE 3 (D3) trial criteria within 6-16 hrs and those who meet DAWN criteria within 6-24… Click to show full abstract

Background: The 2018 ASA guidelines recommend endovascular stroke treatment (EVT) for patients who meet DEFUSE 3 (D3) trial criteria within 6-16 hrs and those who meet DAWN criteria within 6-24 hrs...

Keywords: wmp3 defuse; abstract wmp3; dawn; eligible dawn; dawn ineligible; defuse eligible

Journal Title: Stroke
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.